Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 30,749 | reported | 04 Feb 2022 | tx 7+196,000−5,251 |
| KIORA PHARMACEUTICALS INC | 20,000 | reported | 01 Apr 2025 | tx 6+38,778 |
| Revance Therapeutics, Inc. | 0 | reported | 06 Feb 2025 | tx 3−108,853 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Apr 2025 | GRANT_AWARD | KIORA PHARMACEUTICALS INC | 20,000 | 0.00 USD | deriv |
| 06 Feb 2025 | OTHER | Revance Therapeutics, Inc. | 95,212 | — | |
| 04 Feb 2025 | TENDER | Revance Therapeutics, Inc. | 9,733 | 3.65 USD | |
| 18 Nov 2024 | SALE | Revance Therapeutics, Inc. | 3,908 | 4.17 USD | |
| 01 Jul 2024 | GRANT_AWARD | KIORA PHARMACEUTICALS INC | 1,778 | 0.00 USD | deriv |
| 29 Sept 2023 | GRANT_AWARD | KIORA PHARMACEUTICALS INC | 0 | 0.00 USD | deriv |
| 03 Mar 2023 | GRANT_AWARD | KIORA PHARMACEUTICALS INC | 8,000 | 0.00 USD | deriv |
| 04 Feb 2022 | TAX_WITHHOLDING | AERIE PHARMACEUTICALS INC | 927 | 7.05 USD | |
| 01 Feb 2022 | GRANT_AWARD | KIORA PHARMACEUTICALS INC | 4,000 | 0.00 USD | deriv |
| 01 Feb 2022 | GRANT_AWARD | KIORA PHARMACEUTICALS INC | 5,000 | 0.00 USD | deriv |
| 11 Nov 2021 | TAX_WITHHOLDING | AERIE PHARMACEUTICALS INC | 2,162 | 12.06 USD | |
| 04 Feb 2021 | GRANT_AWARD | AERIE PHARMACEUTICALS INC | 11,000 | 0.00 USD | |
| 04 Feb 2021 | GRANT_AWARD | AERIE PHARMACEUTICALS INC | 50,000 | 0.00 USD | deriv |
| 11 Nov 2020 | TAX_WITHHOLDING | AERIE PHARMACEUTICALS INC | 2,162 | 13.05 USD | |
| 11 Nov 2019 | GRANT_AWARD | AERIE PHARMACEUTICALS INC | 25,000 | 0.00 USD | |
| 11 Nov 2019 | GRANT_AWARD | AERIE PHARMACEUTICALS INC | 110,000 | 0.00 USD | deriv |